跳至主要内容
临床试验/IRCT20210426051090N1
IRCT20210426051090N1尚未招募3 期

The effect of atorvastatin on on inflammatory factors and prognosis outcomes in patients with Covid 19, hospitalized in Hajar Hospital, Shahrekord University of Medical Sciences, 2021

Shahre-kord University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with confirmed molecular test of blood oxygen saturation level SpO2 less than 90% in room air
  • Patients with pulmonary involvement in radiological studies
  • Do not take statins
  • The patient is not in a state of shock and sepsis

排除标准

  • Having advanced heart disease (CHF)
  • Liver disease (based on primary LFT)
  • Incidence of statin side effects
  • Long-term use of corticosteroids
  • Pulmonary underlying disease

研究者

发起方
Shahre-kord University of Medical Sciences

相似试验